A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting

AAPS PharmSciTech

Volumn 9, Issue 3, 2008, Pages 774-781

  Goel, Honey ^a   Vora, Nishant ^a   Rana, Vikas ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Aminoacetic acid; Carmellose; Fast disintegrating tablets; Ondansetron HCl and domperidone

Indexed keywords

ALGINIC ACID; CARBOXYMETHYLCELLULOSE; CROSCARMELLOSE SODIUM; CROSPOVIDONE; DISINTEGRATING AGENT; DOMPERIDONE; GLYCINE; LACTOSE; ONDANSETRON; WATER;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRUSHING STRENGTH; DEPENDENT VARIABLE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA AND VOMITING; NORMAL HUMAN; PROCESS OPTIMIZATION; TABLET DISINTEGRATION TIME;

ADOLESCENT; ADULT; ANTIEMETICS; CHEMISTRY, PHARMACEUTICAL; FEMALE; HUMANS; MALE; MOUTH; NAUSEA; SOLUBILITY; TABLETS; TIME FACTORS; VOMITING; YOUNG ADULT;

EID: 57149132982     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9113-1     Document Type: Article

References (13)

1. R. K. Chang, X. Guo, B. A. Burnside, and R. A. Couch. Fast dissolving tablets. Pharm. Technol. 24: 52-59 (2000).
2. L. Mallet. Caring for the elderly patient. J. Am. Pharm. Assoc. 36: 628 (1996).
3. H. Seager. Drug delivery products and the Zydis fast dissolving dosage. J. Pharm. Pharmacol. 50: 375-382 (1998).
4. S. R. Parakh, and A. V. Gothoskar. A review of mouth dissolving technologies. Pharm. Technol. 27: 92-100 (2003).
5. S. Schiemeir, and P. C. Schmidt. Fast dispersible ibuprofen tablets. Eur. J. Pharm. Sci. 15: 295-305 (2002).
6. J. Fukami, A. Ozawa, Y. Yoshihashi, E. Yonemochi, and K. Terada. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: Evaluation of wetting and disintegration of tablet on the basis of surface free energy. Chem. Pharm. Bull. (Tokyo). 53: 1536-1539 (2005).
7. I. I. Salem, J. M. R. Lopez, and A. C. Galan. Ondansetron hydrochloride. In H. G. Brittain (ed.), Analytical Profiles of Drug Substances and Excipients, vol. 27, Academic, California, 2001, pp. 301-308.
8. J. E. Hoover. Gastrointestinal and liver drugs. In: Hendrickson R (ed) Remington:THe Science and Practice of Pharmacy, 21st edn, Lippincott Williams & Wilkins, USA, PA, 2006, p. 1311.
9. J. Fukami, B. Yonemochi, Y. Yoshihashi, and K. S. Terada. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int. J. Pharm. 310: 101-109 (2006).
10. U. S. Pharmacopoeia. USP 30-NF25, USP, Rockville, MD, 2007.
11. V. B. Sutariya, R. C. Mashru, M. G. Sankalia, and J. M. Sankalia. Preparation of rapidly disintegrating tablets of ondansetron hydrochloride by direct compression method. Ars. Pharm. 47: 293-311 (2006).
12. G. A. Lewis, D. Mathieu, and R. Phan-Tan-Luu. The scope of experimental design. In G. A. Lewis, D. Mathieu, and R. Phan-Tan-Luu (eds.), Pharmaceutical Experimental Designs, Marcel Dekker, NewYork, 1999, p. 50.
13. X. Y. Bi, H. Sunada, Y. Yonezawa, and K. Danjo. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev. Ind. Pharm. 25: 571-581 (1999).